4.7 Editorial Material

Rivaroxaban after laparoscopic cancer surgery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer

Cecilia Becattini et al.

Summary: Rivaroxaban is more effective than placebo in extended prevention of VTE after laparoscopic surgery for colorectal cancer without increasing the risk of major bleeding.
Article Hematology

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial

Jodi Mones et al.

Summary: Prophylactic use of rivaroxaban significantly reduced the risk of cancer-associated thrombosis in patients, but may increase the risk of gastrointestinal bleeding in patients with tumors at the gastric/gastroesophageal junction. Patients with gastric/gastroesophageal junction tumors had a higher risk of bleeding events when treated with rivaroxaban compared to those with non-G/GEJ tumors.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Article Medicine, General & Internal

Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY

Cecilia Becattini et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

D Bergqvist et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)